Johnson Matthew B, De Franco Elisa, Lango Allen Hana, Al Senani Aisha, Elbarbary Nancy, Siklar Zeynep, Berberoglu Merih, Imane Zineb, Haghighi Alireza, Razavi Zahra, Ullah Irfan, Alyaarubi Saif, Gardner Daphne, Ellard Sian, Hattersley Andrew T, Flanagan Sarah E
Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
The Royal Hospital Oman, Muscat, Oman.
Diabetes. 2017 Aug;66(8):2316-2322. doi: 10.2337/db17-0040. Epub 2017 May 4.
Young-onset autoimmune diabetes associated with additional autoimmunity usually reflects a polygenic predisposition, but rare cases result from monogenic autoimmunity. Diagnosing monogenic autoimmunity is crucial for patients' prognosis and clinical management. We sought to identify novel genetic causes of autoimmunity presenting with neonatal diabetes (NDM) (diagnosis <6 months). We performed exome sequencing in a patient with NDM and autoimmune lymphoproliferative syndrome and his unrelated, unaffected parents and identified compound heterozygous null mutations in Biallelic mutations cause common variable immunodeficiency-8; however, NDM has not been confirmed in this disorder. We sequenced in 169 additional patients with diabetes diagnosed <1 year without mutations in the 24 known NDM genes. We identified recessive null mutations in 8 additional probands, of which, 3 had NDM (<6 months). Diabetes was the presenting feature in 6 of 9 probands. Six of 17 (35%) patients born to consanguineous parents and with additional early-onset autoimmunity had recessive mutations. testing should be considered in patients with diabetes diagnosed <12 months, particularly if they have additional autoimmunity or are born to consanguineous parents. A genetic diagnosis is important as it can enable personalized therapy with abatacept, a CTLA-4 mimetic, and inform genetic counseling.
与额外自身免疫相关的早发性自身免疫性糖尿病通常反映多基因易感性,但罕见病例由单基因自身免疫引起。诊断单基因自身免疫对患者的预后和临床管理至关重要。我们试图确定患有新生儿糖尿病(NDM)(诊断时间<6个月)的自身免疫的新遗传原因。我们对一名患有NDM和自身免疫性淋巴增生综合征的患者及其无关的未受影响的父母进行了外显子组测序,并在双等位基因突变中鉴定出复合杂合无效突变,导致常见可变免疫缺陷8;然而,在这种疾病中尚未证实NDM。我们对另外169名诊断为<1岁且24个已知NDM基因无突变的糖尿病患者进行了测序。我们在另外8名先证者中鉴定出隐性无效突变,其中3名患有NDM(<6个月)。糖尿病是9名先证者中其中6名的首发特征。17名(35%)近亲结婚且患有额外早发性自身免疫的患者中有6名有隐性突变。对于诊断为<12个月的糖尿病患者,尤其是那些有额外自身免疫或近亲结婚的患者,应考虑进行基因检测。基因诊断很重要,因为它可以实现使用阿巴西普(一种CTLA-4模拟物)进行个性化治疗,并为遗传咨询提供依据。